Quiz|Articles|December 3, 2025

Guess the Therapy Answer December 3, 2025

What was the second gene therapy product to be approved by the FDA for transfusion-dependent beta-thalassemia?

Answer: exagamglogene autotemcel (exa-cel; marketed as Casgevy)

Newsletter

Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.

Latest CME